Currently out of the existing stock ratings of Kumaraguru Raja, 20 are a BUY (95.24%), 1 are a HOLD (4.76%).

Kumaraguru Raja

Work Performance Price Targets & Ratings Chart

Analyst Kumaraguru Raja, currently employed at BROOKLINE, carries an average stock price target met ratio of 28.33% that have a potential upside of 61.58% achieved within 243 days.

Kumaraguru Raja’s has documented 37 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on OTLK, OUTLOOK THERAPEUTICS INC at 29-Aug-2023.

Wall Street Analyst Kumaraguru Raja

Analyst best performing recommendations are on VERU (VERU).
The best stock recommendation documented was for VERU (VERU) at 12/11/2020. The price target of $17 was fulfilled within 60 days with a profit of $10.64 (167.3%) receiving and performance score of 27.88.

Average potential price target upside

of $10.64 (167.3%) on VERU (VERU).
of $54.67 (356.62%) on EDSA (EDESA BIOTECH).

ARCT Arcturus Therapeutics Holdings FBRX Forte Biosciences VERU Veru SCYX Scynexis CLBS Caladrius Biosciences ADIL Adial Pharmaceuticals DRMA Dermata Therapeutics EDSA Edesa Biotech CYCC Cyclacel Pharmaceuticals OTLK OUTLOOK THERAPEUTICS INC BCDA Biocardia

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Yanan Zhu (WELLS FARGO)